You have read all your free articles, to continue reading subscribe to read the rest of this content.
H. Lundbeck has entered into an agreement with biotech company ImmunoBrain Checkpoint for the rights to IBC's groundbreaking research in the treatment of Alzheimer's disease. The research focuses on modifying antibodies currently used in cancer treatment for use in treating the debilitating brainAlready a subscriber Login You have read all…
Baxter will include Medow's IV-bracelet in its product catalogue for distribution in Sweden. Swedish startup Medow has developed an IV-bracelet, a bracelet which effectively secures intravenous tubes for example at dialysis or intravenous drip. The bracelet has been tested extensively at hospitalAlready a subscriber Login You have read all your…
Genmab has entered an agreement to grant Gilead Sciences, an exclusive license and an option on a second exclusive license, to use the DuoBody technology platform to create and develop bispecific antibody candidates for a therapeutic program targeting HIV. Under the terms of the agreement, GenmabAlready a subscriber Login You…
BC Platforms announced that the Center for Molecular Medicine (CMM) at the Karolinska Institute has extended its research partnership with them to encompass its newest version of the platform and include its BC|GENOME and BC|TILING tools to add capacity for large scale next generation sequencing as Already a subscriber Login…
